Introduction to hepatitis C virus infection: Overview and history of hepatitis C virus therapies
- 25 April 2018
- journal article
- review article
- Published by Wiley in Hemodialysis International
- Vol. 22 (S1) , S8-S21
Abstract
Chronic hepatitis C virus (HCV) infection is an infection that affects over 71 million people worldwide that primarily leads to significant morbidity and mortality through its predisposition to liver fibrosis, cirrhosis, and liver cancer. In addition, extrahepatic manifestations, such as mixed cryoglobulinaemia‐associated vasculitis including renal disease, or type II diabetes are frequently encountered in chronically infected individuals. HCV treatment aims to permanently eradicate the virus in order to prevent both liver and extra‐hepatic manifestations. Over two decades after the HCV discovery, treatments have evolved from nonspecific immune modulating therapies based on interferon to specific drug combinations, targeting viral proteins. In the present review, we give an overview of HCV infection with a special emphasis on the history of the treatment of viral hepatitis C and the substantial improvement in efficacy and tolerability profile with the recent development of new direct‐acting antiviral therapies.Keywords
This publication has 108 references indexed in Scilit:
- Epidemiology and natural history of HCV infectionNature Reviews Gastroenterology & Hepatology, 2013
- Chronic Hepatitis C Is Associated With Peripheral Rather Than Hepatic Insulin ResistanceGastroenterology, 2010
- Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C #Hepatology, 2009
- Association of Hepatitis C Seropositivity With Increased Risk for Developing End-stage Renal DiseaseArchives of internal medicine (1960), 2007
- Dynamic Hepatitis C Virus Genotypic and Phenotypic Changes in Patients Treated With the Protease Inhibitor TelaprevirGastroenterology, 2007
- The Hepatitis C Virus Life Cycle as a Target for New Antiviral TherapiesGastroenterology, 2007
- Impaired Irs–1/Pi3–Kinase Signaling in Patients With Hcv: A Mechanism for Increased Prevalence of Type 2 DiabetesHepatology, 2003
- Hepatitis C Virus Infection and de Novo Glomerular Lesions in Renal AllograftsAmerican Journal of Transplantation, 2001
- Hepatitis C virus in kidney recipientsJournal of Hepatology, 1992
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989